Hosted a 2026 outlook webinar discussing portfolio company Syntara.
Syntara is a clinical-stage drug development company focused on developing novel medicines for blood cancers and conditions linked to inflammation and fibrosis, leveraging expertise in amine oxidase chemistry
Syntara is a clinical-stage drug development company focused on developing novel medicines for blood cancers and conditions linked to inflammation and fibrosis, leveraging expertise in amine oxidase chemistry.